Navigation Links
CareFusion Reports First Quarter Fiscal 2012 Results
Date:11/7/2011

nrecurring(in millions)GAAP(4)Items(2)Adjusted(3)Medical SystemsRevenue$

468

$

-

$

468Operating Income $

68

$

22

$

90Procedural SolutionsRevenue$

343

$

-

$

343Operating Income $

11

$

17

$

28____________1Reflects nonrecurring charges primarily related to the spinoff and nonrecurring restructuring charges.  2Reflects nonrecurring charges primarily related to the spinoff and nonrecurring restructuring and acquisition integration charges.  Certain nonrecurring costs previously reported were applicable to the International Surgical Products (ISP) business and therefore were reclassified to be reflected as part of that business.3Adjusted financial information reflects GAAP results adjusted on a non-GAAP basis to exclude nonrecurring items noted.4Previously reported GAAP amounts have been adjusted to reflect the impact of the divestiture of the ISP business, and re-segmentation of the Company's businesses into two new reportable segments.  The ISP business was divested in April 2011, and has been classified as discontinued operations. CAREFUSION CORPORATIONSEGMENT AND SELECT BUSINESS LINE REVENUES(UNAUDITED)Quarter Ended September 30,(in millions) 20112010(1)Percent
ChangeMedical SystemsDispensing Technologies

$

237

$

205

16

%Infusion Systems206192

7Respiratory Technologies6065

(8)Other66

-Total Medical Systems

$

509

$

468

9Procedural SolutionsInfection Prevention

$

138

$

135

2

%Medical Specialties7878

-Specialty Disposables6670

(6)Other5360

(12)Total Procedural Solutions

$

335

$

343

(2)Total CareFusion$

844

$

811

4

%____________1Previously rep
'/>"/>

SOURCE CareFusion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation
2. Sequenom, Inc. Reports Financial Results for the Third Quarter of 2011
3. InterMune Reports Third Quarter 2011 Financial Results and Business Highlights
4. Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results
6. Caliper Life Sciences Reports Third Quarter 2011 Results
7. Neurocrine Biosciences Reports Third Quarter 2011 Results
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. Sangamo BioSciences Reports Third Quarter 2011 Financial Results
10. Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
11. ReportsnReports: Depression Therapeutics Market to Reach $10.9 Billion by 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 Spartan Bioscience announced today ... CYP2C19 System . It detects CYP2C19 genetic mutations in ... , The Spartan RX CYP2C19 System is the first ... approved in Canada. Due to the system’s ease of ... used by healthcare professionals such as doctors, nurses, pharmacists, ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success and ... its fleet of high volume High Pressure Processing (HPP) systems. ... return to PackExpo this year, which is where we first ... Jeff Williams, CEO at Avure. “Sales of the new Avure ... meeting the challenges of market demand for higher throughput. We ...
(Date:10/30/2014)... 2014 Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... will present a company overview at the Nomura Biotechnology Conference ... Boston, MA. A live ... & Media" section of the Company,s website, www.isispharm.com .  ... 48 hours and will be archived for a limited time. ...
(Date:10/30/2014)...  Regado Biosciences, Inc. (Nasdaq: RGDO ), ... and live audio webcast on Thursday, November 6, 2014, ... 2014 financial results. Interested participants and investors ... for domestic callers or (412) 902-4276 for international callers. ... investor relations section of the Regado website at ...
Breaking Biology Technology:Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Regado Biosciences to Provide Third Quarter 2014 Financial Results 2
... most common lethal fungal infection is caused by a ... leukemia and HIV/AIDS patients at serious risk. OpGen ... whole genome map of this fungal pathogen that will ... find new therapeutics to treat this, and other deadly ...
... The recent onslaught of e-mail viruses, overabundant spam and ... user protection. In light of this, TDS Telecom ... recently began offering new computer security technologies to their ... U.S. corporations $8.9 billion dollars in 2002 through lost ...
... Wis.--API Software, Inc., formerly known as Automating Peripherals, ... the company. API Software, Inc. is ... human resources, productivity management, education tracking and access ... 20 years of evolving our products while serving ...
Cached Biology Technology:OpGen Creates Map of Worlds Most Lethal Fungus 2Wisconsin Telcos Offer New Internet Security Solutions 2
(Date:10/31/2014)... the war against Ebola one important hurdle has just ... at the University of North Carolina at Chapel Hill ... mice that can be infected with Ebola and display ... published in the current issue of Science , ... vaccines, which are desperately needed to curb the worldwide ...
(Date:10/31/2014)... Adelaide-led project has developed a new test that can ... H5N1 strain of avian influenza virus or "bird flu" ... is a significant step in the fight against this ... in the poultry populations of South East Asia, particularly ... of its possible transmission to humans and the threat ...
(Date:10/31/2014)... 2014  HITLAB SM , a healthcare innovation ... inaugural HITLAB Innovators Summit SM on December ... will partner with the Clinton Foundation,s Health Matters ... Columbia Business School Alumni Club of ... and Operations Research, bringing together leaders in healthcare ...
Breaking Biology News(10 mins):Improved mouse model will accelerate research on potential Ebola vaccines, treatments 2New step towards eradication of H5N1 bird flu 2HITLAB Announces Inaugural HITLAB Innovators Summit 2HITLAB Announces Inaugural HITLAB Innovators Summit 3
... Listening for faint rustling noises made by tasty beetles on ... exquisitely sensitive hearing. So try imagining what it must be ... roaring highway. It would seem to be almost impossible to ... or is it? How animals that locate their prey by ...
... at Purdue University suggests synthetic carbon molecules called ... being accumulated in animal tissue, but the molecules ... reducing their possible environmental dangers. Buckyballs may ... from drug-delivery vehicles for cancer therapy to ultrahard ...
... Hospital investigators have gained new insight into how the ... to a confusion of lethally malfunctioning molecules without a ... their function. Just as eyeglasses improve vision, ... rain, cells use a set of proteins called ubiquitin-like ...
Cached Biology News:Bats pick up rustling sounds against highway background noise 2'Buckyballs' have high potential to accumulate in living tissue 2'Buckyballs' have high potential to accumulate in living tissue 3St. Jude study gives new insights into how cells accessorize their proteins 2St. Jude study gives new insights into how cells accessorize their proteins 3
... Signet offers the most comprehensive, cost-effective ... We have incorporated unprecedented quality into ... This includes proven detection chemistries and ... the TechMate protocol. It also includes ...
... Detection System combines the indirect labeling ... and Signets unique formulation of ultra ... reliablility. Signet reagents will achieve excellent ... automated protocols. ,Signets USA Detection reagents ...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
Biology Products: